Lymphoblastic Leukemia, Acute, Childhood Completed Phase 1 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0044925 (Lymphoblastic Leukemia, Acute, Childhood)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01411267AC220 for Children With Relapsed/Refractory ALL or AMLTreatment
NCT01321346A Study Of Panobinostat In Children With Refractory Hematologic MalignanciesTreatment
NCT01861002A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AMLTreatment